BC Cancer
Industry
- Academic and Research Institutions
Latest on BC Cancer
IN VITRO DIAGNOSTICS Austrian Academy of Sciences CeMM Research Center for Molecular Medicine Qiagen NV Qiagen licenses myeloproliferative neoplasm biomarker from CeMM The Austrian Academy of
IN VITRO DIAGNOSTICS Mergers & Acquisitions Oxford Gene Technology Ltd. Cytocell Technologies Ltd. Genetics research and biomarker discovery firm Oxford Gene Technology Ltd. (OGT) bought fellow UK
IN VITRO DIAGNOSTICS Mergers & Acquisitions Becton Dickinson & Co. Alverix Inc. Becton Dickinson & Co. acquired its privately held point-of-care testing partner Alverix Inc. (optoelectronics)
IN VITRO DIAGNOSTICS BC Cancer Agency Columbia University Qiagen NV Qiagen licenses biomarker rights from Columbia University and the BC Cancer Agency Assay and molecular diagnostics devel